LectureLinx en PAYCE kondigen een wereldwijde uitbreiding aan via een wereldwijde exclusieve licentieovereenkomst om technologieën en diensten voor de farmaceutische industrie te combineren
–News Direct–
LectureLinx, een leider op het gebied van nalevingstechnologieën voor de farmaceutische en life science-sector, en PAYCE, een toonaangevende leverancier van farmaceutische technologie voor zorgprofessionals (HCP’s) en zorgorganisaties (HCO’s) in Europa, hebben overeenstemming bereikt over een exclusieve wereldwijde licentie om de belangrijkste PAYCE-technologieën te integreren en diensten in het LectureLinx-platform en -systemen in een wereldwijd initiatief om de manier waarop zorgverleners en de farmaceutische industrie samenwerken te transformeren.
In de afgelopen tien jaar hebben farmaceutische en biowetenschappelijke bedrijven in verschillende landen nieuwe vereisten voor transparantierapportage ingevoerd, terwijl ze de impact op de HCP proberen te minimaliseren en ervoor zorgen dat hun systemen en processen zeer effectief blijven. Steeds meer bedrijven richten zich nu volledig op de HCP-ervaring. Met voortdurende operationele uitdagingen, rapportage, tracking, audit en meer, zagen LectureLinx en PAYCE de mogelijkheid om hun krachten te bundelen om beide problemen op te lossen.
LectureLinx and PAYCE Announce a Global Expansion Through a Worldwide Exclusive Licensing Agreement to Combine Technologies and Services for the Pharmaceutical Industry
–News Direct–
LectureLinx, a leader in compliance technologies for the pharmaceutical and life science industries, and PAYCE, a leading pharmaceutical technology provider for healthcare professionals (HCPs) and healthcare organizations (HCOs) in Europe, have agreed to an exclusive global license to integrate key PAYCE technologies and services into the LectureLinx platform and systems in a worldwide initiative to transform how healthcare practitioners and the pharmaceutical industry collaborate.
In the last decade pharmaceutical and life science companies have adopted new transparency reporting requirements across different countries, whilst seeking to minimise the impacts on the HCP and ensuring that their systems and processes remain highly effective. More and more companies are now fully focused on the HCP experience. With continued operational challenges, reporting, tracking, audit and more, LectureLinx and PAYCE saw the opportunity to combine forces to solve both problems.
Based in the U.S., LectureLinx will develop and commercialize the multi-functional PAYCE platform, which has an established reputation across the European pharma market. The purpose-built industry platform offers a new standard in compliance technologies for the pharmaceutical industry, as well as proven solutions, which include streamlined contracting and faster HCP payments, as well as strengthening disclosure reporting, while recognizing regional differences across international markets.
The two companies will combine their expertise and experience across different locations and their understanding of local markets to operate as a single global provider, delivering expanded offerings and reach, a broader set of solutions, and increased benefits to existing and future clients.
“Years of real-world market experience allow LectureLinx and PAYCE to combine forces to make this bold and brave move. Together, we provide a unique, fully integrated solution across the globe, which no other provider can offer or match,” said LectureLinx Founder and CEO Ellen Varelas. “It’s challenging to navigate the pharmaceutical markets both in the U.S. and EU. But together, with integrated solutions and strategies and future investment in development, we will enable our pharmaceutical clients to offer unparalleled experiences for healthcare providers and organizations.”
“We are leveraging our shared synergies and combining our solutions to fulfill a global need for pharma and, more importantly, a better experience for HCPs and HCOs worldwide,” said PAYCE Founder and CEO David Bloomfield. “Every business that is looking to strengthen its compliance and improve HCP engagement on a global scale will benefit.”
LectureLinx’s global headquarters will remain in the US. The European headquarters will be located in the UK. To learn more, please visit: www.lecturelinx.com
About LectureLinx
Founded in 2001, LectureLinx is a technology company providing pharmaceutical and life science companies with an ecosystem of innovative products and platforms designed to improve operational efficiency and reduce risk with the confidence that processes are compliant, auditable, and reportable. LectureLinx’s solutions are imminently scalable and supported by over 20 years of real-world expertise and hands-on market experience. As trusted advisors and solution providers, LectureLinx provides world-class and fully integrated solutions while ensuring a best-in-class experience for end users. Learn more at lecturelinx.com
About PAYCE
PAYCE is a dedicated, purpose-built portal offering a new standard in compliance technologies for the pharmaceutical industry. It is also a specialist contracting and payment tool that offers an unrivalled experience for pharmaceutical companies, healthcare professionals and healthcare organisations. PAYCE streamlines contracting and payment processes, removing complexity so that users can focus on execution. PAYCE is used by leading pharmaceutical companies and thousands of HCPs and HCOs.
Contact Details
Jennifer Cronin
lecturelinx@trustrelations.agency
Carole Ayemaung
carole.ayemaung@cofinitive.com
View source version on newsdirect.com: https://newsdirect.com/news/lecturelinx-and-payce-announce-a-global-expansion-through-a-worldwide-exclusive-licensing-agreement-to-combine-technologies-and-services-for-the-pharmaceutical-industry-189414297
Check out our twitter: @NewsNovumpr